Pembrolizumab (MK-3475) in Hepatocellular Carcinoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of California, Davis
Mayo Clinic
Rigshospitalet, Denmark
Chinese University of Hong Kong
Ain Shams University
Alexandria University
H. Lee Moffitt Cancer Center and Research Institute
University of Miami
Al-Azhar University
University of La Laguna
University of Texas Southwestern Medical Center
Karolinska Institutet
Mansoura University
Cairo University
Arbor Research Collaborative for Health
Icahn School of Medicine at Mount Sinai
University of California, Irvine
Arbor Research Collaborative for Health
Hospices Civils de Lyon
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Henry Ford Health System
University Hospital Freiburg
National Cancer Institute, Milan